Go Pro
NASDAQ:SGRY

Surgery Partners (SGRY) Stock Price, News & Analysis

Surgery Partners logo
$15.55 -0.10 (-0.63%)
As of 02:01 PM Eastern
This is a fair market value price provided by Massive. Learn more.

About Surgery Partners Stock (NASDAQ:SGRY)

Advanced

Key Stats

Today's Range
$15.00
$15.69
50-Day Range
$13.22
$17.23
52-Week Range
$11.41
$24.10
Volume
621,853 shs
Average Volume
1.51 million shs
Market Capitalization
$2.03 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$21.60
Consensus Rating
Moderate Buy

Company Overview

Surgery Partners, Inc. operates as a healthcare services provider specializing in the management and ownership of ambulatory surgery centers, surgical hospitals and multispecialty rehabilitation hospitals across the United States. Through its network of facilities, the company coordinates and delivers a broad range of outpatient surgical procedures in specialties such as orthopedics, ophthalmology, otolaryngology, gastroenterology, pain management and general surgery. Its integrated platform offers ancillary services including on-site imaging, laboratory testing, infusion therapy and physical, occupational and speech rehabilitation.

Since its establishment in 2010 and subsequent public listing in 2015, Surgery Partners has focused on strategic partnerships with physicians and health systems to expand access to cost-effective outpatient care. The company deploys a capital-light management services model as well as joint-venture ownership structures to develop and acquire facilities in mid-sized and underserved markets. As of the most recent disclosures, Surgery Partners maintains operations in more than 25 states, serving patients through over 200 ambulatory surgery centers and multiple inpatient surgical and rehabilitation hospitals.

Headquartered in Nashville, Tennessee, Surgery Partners emphasizes clinical governance and regulatory compliance, leveraging standardized protocols to drive quality outcomes and operational efficiency. The leadership team is led by President and Chief Executive Officer Douglas Coltharp, who brings extensive experience in healthcare strategy, capital markets and operations. Under Coltharp’s guidance, the company continues to pursue selective growth opportunities while maintaining collaborative relationships with physician partners and payors to address the evolving demands of value-based care.

AI Generated. May Contain Errors.

Surgery Partners Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
75th Percentile Overall Score

SGRY MarketRank™: 

Surgery Partners scored higher than 75% of companies evaluated by MarketBeat, and ranked 168th out of 900 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Surgery Partners has received a consensus rating of Moderate Buy. The company's average rating score is 2.73, and is based on 1 strong buy rating, 7 buy ratings, 2 hold ratings, and 1 sell rating.

  • Upside Potential

    Surgery Partners has a consensus price target of $21.60, representing about 40.1% upside from its current price of $15.42.

  • Amount of Analyst Coverage

    Surgery Partners has only been the subject of 2 research reports in the past 90 days.

  • Read more about Surgery Partners' stock forecast and price target.
  • Earnings Growth

    Earnings for Surgery Partners are expected to grow by 40.00% in the coming year, from $0.25 to $0.35 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Surgery Partners is -25.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Surgery Partners is -25.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    Surgery Partners has a PEG Ratio of 4.80. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Surgery Partners has a P/B Ratio of 0.64. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Surgery Partners' valuation and earnings.
  • Percentage of Shares Shorted

    11.55% of the float of Surgery Partners has been sold short.
  • Short Interest Ratio / Days to Cover

    Surgery Partners has a short interest ratio ("days to cover") of 11.41, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Surgery Partners has recently decreased by 2.13%, indicating that investor sentiment is improving.
  • Dividend Yield

    Surgery Partners does not currently pay a dividend.

  • Dividend Growth

    Surgery Partners does not have a long track record of dividend growth.

  • News Sentiment

    Surgery Partners has a news sentiment score of 1.08. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.64 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for Surgery Partners this week, compared to 3 articles on an average week.
  • Search Interest

    4 people have searched for SGRY on MarketBeat in the last 30 days.
  • MarketBeat Follows

    1 people have added Surgery Partners to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Surgery Partners insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    2.00% of the stock of Surgery Partners is held by insiders.

  • Percentage Held by Institutions

    Surgery Partners has minimal institutional ownership at this time.

  • Read more about Surgery Partners' insider trading history.
Receive SGRY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Surgery Partners and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SGRY Stock News Headlines

Surgery Partners (SGRY) to Post Quarterly Earnings on Monday
Porter flew 3,300 miles to investigate this system
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business.tc pixel
See More Headlines

SGRY Stock Analysis - Frequently Asked Questions

Surgery Partners' stock was trading at $15.45 at the beginning of 2026. Since then, SGRY shares have decreased by 0.2% and is now trading at $15.4180.

Surgery Partners, Inc. (NASDAQ:SGRY) released its quarterly earnings results on Tuesday, May, 5th. The company reported ($0.03) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.15) by $0.12. The firm's quarterly revenue was up 4.5% on a year-over-year basis.
Read the conference call transcript
.

Surgery Partners' Board of Directors approved a stock repurchase program on Thursday, February 26th 2026, which authorizes the company to buy back $200,000,000 in outstanding shares, according to EventVestor. This means that the company could purchase up to 9.7% of its shares through open market purchases. Shares buyback programs are typically an indication that the company's leadership believes its shares are undervalued.

Surgery Partners (SGRY) raised $350 million in an initial public offering on Thursday, October 1st 2015. The company issued 14,285,000 shares at a price of $23.00-$26.00 per share.

Shares of SGRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Surgery Partners investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), Palo Alto Networks (PANW), ServiceNow (NOW) and Adobe (ADBE).

Company Calendar

Last Earnings
5/05/2026
Today
8/05/2026
Next Earnings (Estimated)
8/10/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Providers & Services
Sub-Industry
Healthcare Facilities
Current Symbol
NASDAQ:SGRY
CIK
1638833
Employees
16,000
Year Founded
2004

Price Target and Rating

High Price Target
$36.00
Low Price Target
$14.00
Potential Upside/Downside
+38.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.73
Research Coverage
11 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.60)
Trailing P/E Ratio
N/A
Forward P/E Ratio
62.20
P/E Growth
4.8
Net Income
-$77.90 million
Net Margins
-2.28%
Pretax Margin
3.41%
Return on Equity
1.04%
Return on Assets
0.41%

Debt

Debt-to-Equity Ratio
1.17
Current Ratio
1.86
Quick Ratio
1.69

Sales & Book Value

Annual Sales
$3.31 billion
Price / Sales
0.61
Cash Flow
$1.65 per share
Price / Cash Flow
9.41
Book Value
$24.21 per share
Price / Book
0.64

Miscellaneous

Outstanding Shares
130,790,000
Free Float
128,172,000
Market Cap
$2.03 billion
Optionable
Optionable
Beta
1.91

Social Links

10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

This page (NASDAQ:SGRY) was last updated on 8/5/2026 by MarketBeat.com Staff.
From Our Partners